| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| N1-(4-CYANO-2-ETHYLPHENYL)ACETAMIDE |
N1-(4-氰基-2-乙基苯基)乙酰胺 |
34921-76-1 |
詳細
|
| Recilisib |
RECILISIB 鈉鹽 |
334969-03-8 |
詳細
|
| PF-03814735 |
N-[2-[(1S,4R)-6-[[4-(環(huán)丁基氨基)-5-(三氟甲基)-2-嘧啶基]氨基]-1,2,3,4-四氫萘-1,4-亞氨-9-基]-2-氧代乙基]乙酰胺 |
942487-16-3 |
詳細
|
| Cenisertib |
R763(AS-703569) |
871357-89-0 |
詳細
|
| sodiuM 1,5-bis((4-Methoxybenzyl)oxy)-4-oxo-1,4-dihydropyridine-2-carboxylate |
sodiuM 1,5-bis((4-Methoxybenzyl)oxy)-4-oxo-1,4-dihydropyridine-2-carboxylate |
1401528-97-9 |
詳細
|
| XL228 |
N4-(5-環(huán)丙基-1H-吡唑-3-基)-N2-[[3-異丙基-5-異惡唑基]甲基]-6-(4-甲基-1-哌嗪基)-2,4-嘧啶二胺 |
898280-07-4 |
詳細
|
| 2-aMino-N-(prop-2-ynyl)acetaMide hydrochloride |
2-氨基-N-2-丙炔-1-基乙酰胺鹽酸鹽 |
1221722-25-3 |
詳細
|
| LY2857785 |
LY-2857785 |
1619903-54-6 |
詳細
|
| THZ1 |
THZ1 |
1604810-83-4 |
詳細
|
| 1,5-bis((4-methoxybenzyl)oxy)-4-oxo-1,4-dihydropyridine-2-carboxylic acid |
1,5-bis((4-methoxybenzyl)oxy)-4-oxo-1,4-dihydropyridine-2-carboxylic acid |
141703-10-8 |
詳細
|
| 2-BROMOACETAMIDO-5-CHLOROBENZOPHENONE |
2-(2-溴乙酰氨基)-5-氯二苯甲酮 |
32580-26-0 |
詳細
|
| AZ960 |
5-氟-2-[[(1S)-1-(4-氟苯基)乙基]氨基]-6-[(5-甲基-1H-吡唑-3-基)氨基]-3-吡啶腈 |
905586-69-8 |
詳細
|
| Agerafenib |
CEP 32496 |
1188910-76-0 |
詳細
|
| KU-0060648 |
KU-0060648 |
881375-00-4 |
詳細
|
| Onvansertib |
4,5-二氫-1-(2-羥基乙基)-8-[[5-(4-甲基-1-哌嗪基)-2-(三氟甲氧基)苯基]氨基]-1H-吡唑并[4,3-H]喹唑啉-3-甲酰胺 |
1034616-18-6 |
詳細
|
| 2-(4-fluorophenyl)-5-(2-Methylbenzyl)thiophene |
卡格列凈雜質(zhì)1 |
2005454-69-1 |
詳細
|
| BGB-283 |
BGB-TG-P1 |
1446090-77-2 |
詳細
|
| GSK321 |
GSK321 |
1816331-63-1 |
詳細
|
| 4-BROMO-2-ETHYLACETANILIDE |
4-溴-2-乙基乙酰苯胺 |
51688-73-4 |
詳細
|
| Domatinostat |
(2E)-N-(2-氨基苯基)-3-[1-[[4-(1-甲基-1H-吡唑-4-基)苯基]磺?；鵠-1H-吡咯-3-基]-2-丙烯酰胺 |
910462-43-0 |
詳細
|
| Mivebresib |
米維布塞 |
1445993-26-9 |
詳細
|
| Samotolisib |
LY-3023414 |
1386874-06-1 |
詳細
|
| 1-(3,4-DICHLORO-PHENYL)-PENTAN-1-ONE |
1-(3,4-二氯苯基)戊-1-酮 |
68120-72-9 |
詳細
|
| 3-AMINO-1H-PYRROLE-2,4-DICARBOXYLIC ACID DIETHYL ESTER |
3-氨基-1H-吡咯-2,4-二甲酸2,4-二乙酯 |
853058-40-9 |
詳細
|
| Resminostat |
RESMINOSTAT; 4SC-201; RAS2410 |
864814-88-0 |
詳細
|
| Tucatinib |
妥卡替尼 |
937263-43-9 |
詳細
|
| PF-03758309 |
PF-3758309 |
898044-15-0 |
詳細
|
| GDC-0152 |
GDC-0152 |
873652-48-3 |
詳細
|
| PF-04880594 |
3-[[4-[1-(2,2-二氟乙基)-3-(1H-吡咯并[2,3-B]吡啶-5-基)-1H-吡唑-4-基]-2-嘧啶基]氨基]-丙腈 |
1111636-35-1 |
詳細
|
| Carbonic acid, (3aR,4S,7R,7aS)-1,3,3a,4,7,7a-hexahydro-1,3-dioxo-4,7-Methano-2H-isoindol-2-yl (4-nitrophenyl)Methyl ester, rel- |
碳酸 REL-(3AR,4S,7R,7AS)-1,3,3A,4,7,7A-六氫-1,3-二氧代-4,7-甲橋-2H-異吲哚-2-基 (4-硝基苯基)甲基酯 |
1154758-31-2 |
詳細
|
| Voruciclib |
VORUCICLIB |
1000023-04-0 |
詳細
|
| Nazartinib |
EGF816 |
1508250-71-2 |
詳細
|
| Onatasertib |
CC-223 |
1228013-30-6 |
詳細
|
| GNF-6231 |
GNF6231 |
1243245-18-2 |
詳細
|
| Fenebrutinib |
GDC-0853 |
1434048-34-6 |
詳細
|
| Darovasertib |
LXS-196 |
1874276-76-2 |
詳細
|
| CPI-1205 |
CPDB1215 |
1621862-70-1 |
詳細
|
| KU-0063794 |
KU-0063794 |
938440-64-3 |
詳細
|
| 4-Ethyl hydrogen 1-methyl-1h-pyrazole-4,5-dicarboxylate , 97% |
1-甲基-5-羧基-1H吡唑-4-甲酸乙酯 |
81303-65-3 |
詳細
|
| TAK-733 |
TAK733 |
1035555-63-5 |
詳細
|
| AZ505 ditrifluoroacetate |
N-環(huán)己基-3-[[2-(3,4-二氯苯基)乙基]氨基]-N-[2-[[2-(3,4-二氫-5-羥基-3-氧代-2H-1,4-苯并惡嗪-8-基)乙基]氨基]乙基]丙酰胺 二(2,2,2-三氟乙酸鹽) |
1035227-44-1 |
詳細
|
| 5-(benzyloxyMethyl)-4-Methoxy-5H-pyrrolo[3,2-d]pyriMidine |
4-甲氧基-5-[(苯基甲氧基)甲基]-5H-吡咯并[3,2-D]嘧啶 |
1026012-16-7 |
詳細
|
| CEP-28122 |
5MG |
1022958-60-6 |
詳細
|
| Encorafenib |
康奈非尼 |
1269440-17-6 |
詳細
|
| 4-broMo-3-ethyl-Benzonitrile |
4-溴-3-乙基苯甲腈 |
170230-29-2 |
詳細
|
| Erdafitinib |
厄達替尼 |
1346242-81-6 |
詳細
|
| 4-nitro-2,3-dihydro-1H-inden-1-ol |
4-硝基-2,3-二氫-1H-茚-1-醇 |
56124-60-8 |
詳細
|
| PIM447 |
LGH447 |
1210608-43-7 |
詳細
|
| (3R,5S)-1-(tert-butoxycarbonyl)piperidine-3,5-dicarboxylic acid |
(3R,5S)-1-(tert-butoxycarbonyl)piperidine-3,5-dicarboxylic acid |
534572-17-3 |
詳細
|
| Tozasertib |
陶扎色替 |
639089-54-6 |
詳細
|
| Refametinib |
瑞法替尼 |
923032-37-5 |
詳細
|
| (6-HYDROXY-BENZOFURAN-3-YL)-ACETIC ACID METHYL ESTER |
(6-羥基苯并呋喃-3-基)乙酸甲酯 |
726174-52-3 |
詳細
|
| BMS-911543 |
BMS-911543 |
1271022-90-2 |
詳細
|
| CEP-33779 |
N-[3-(4-甲基-1-哌嗪基)苯基]-8-[4-(甲磺?；?苯基]-[1,2,4]三唑并[1,5-A]吡啶-2-胺 |
1257704-57-6 |
詳細
|
| 2-(6-Hydroxy-2,3-dihydrobenzofuran-3-yl)acetic acid |
2-(6-羥基-2,3-二氫苯并呋喃-3-基)乙酸 |
1000414-37-8 |
詳細
|
| NMS-P715 |
NMS-P715 |
1202055-32-0 |
詳細
|
| Naquotinib |
NAQUOTINIB |
1448232-80-1 |
詳細
|
| PF-06459988 |
化合物PF-06459988 |
1428774-45-1 |
詳細
|
| IDH-305 |
IDH305 |
1628805-46-8 |
詳細
|
| (Tert-Butoxy)Carbonyl Phe-D-Phe-OH |
BOC-PHE-D-PHE-OH |
93397-22-9 |
詳細
|
| Benzamide, 4-bromo-3-ethyl- |
4-溴-3-乙基苯甲酰胺 |
1228826-63-8 |
詳細
|
| Ethanone, 1-(4-bromo-3-ethylphenyl)- |
1-(4-溴-3-乙基苯基)乙烷-1-酮 |
2386092-46-0 |
詳細
|
| 5H-Pyrrolo3,2-dpyrimidine, 7-bromo-4-methoxy-5-(phenylmethoxy)methyl- |
7-N-芐氧基甲基-9-溴-9-去氮-6-O-甲基次黃嘌呤 |
299916-62-4 |
詳細
|
| 1,2-Benzenedimethanol,3-fluoro-(9CI) |
7-溴吡咯并[2,1-F][1,2,4]三嗪-4-胺 |
160485-42-7 |
詳細
|
| 1-(INDOL-3-YL)-2-METHYLPROPAN-2-AMINE |
1-(1H-吲哚-3-基)-2-甲基丙烷-2-胺 |
1202551-93-6 |
詳細
|
| (2R,4S,5R)-3-(tert-butoxycarbonyl)-2-(4-Methoxyphenyl)-4-phenyloxazolidine-5-carboxylic acid |
(4S,5R)-2-(4-甲氧基苯基)-4-苯基-3,5-惡唑烷二羧酸 3-叔丁酯 |
155396-69-3 |
詳細
|
| Ravoxertinib |
GDC-0994 |
1453848-26-4 |
詳細
|
| 6-amino-4-(2,4-dimethoxyphenyl)-[1,2]dithiolo[4,3-b]pyrrol-5(4H)-one hydrochloride |
6-氨基-4-(2,4-二甲氧基苯基)-[1,2]二硫雜環(huán)戊烯[4,3-B]吡咯-5(4H)-酮鹽酸鹽 |
608132-51-0 |
詳細
|
| 1,4-Benzenedicarboxylicacid,1-(4-hydroxybutyl)ester |
4-(4-羥基丁氧基羰基)苯甲酸 |
63317-89-5 |
詳細
|
| GSK484 hydrochloride |
CS-2265 |
1652591-81-5 |
詳細
|
| 2-methyl-1,4,5,6-tetrahydrobenzo[b]imidazo[4,5-d]azepine hydrochloride |
|
182202-73-9 |
詳細
|
| (5-(4-fluorophenyl)thiophen-2-yl)(5-iodo-2-methylphenyl)methanol |
卡那列凈雜質(zhì)66 |
1818268-45-9 |
詳細
|
| AS-605240 |
5-(6-喹喔啉亞甲基)-2,4-噻唑啉二酮 |
648450-29-7 |
詳細
|
| PLX-4720 |
N-[3-[(5-氯-1H-吡咯并[2,3-B]吡啶-3-基)羰基]-2,4-二氟苯基]-1-丙磺酰胺 |
918505-84-7 |
詳細
|
| RO4987655 |
RO4987655(CH4987655) |
874101-00-5 |
詳細
|
| CAY10505 |
CAY10505 |
1218777-13-9 |
詳細
|
| LGK974 |
2',3-二甲基-N-[5-(2-吡嗪基)-2-吡啶基]-[2,4'-聯(lián)吡啶]-5-乙酰胺 |
1243244-14-5 |
詳細
|
| LY3009120 |
LY-3009120 |
1454682-72-4 |
詳細
|
| CC-401 |
|
862832-38-0 |
詳細
|
| AZD9496 |
(E)-3-[3,5-二氟-4-[(1R,3R)-2-(2-氟-2-甲基丙基)-3-甲基-2,3,4,9-四氫-1H-吡啶并[3,4-B]吲哚-1-基]苯基]丙烯酸 |
1639042-08-2 |
詳細
|
| CFI-401870 |
CFI401870 |
1430741-35-7 |
詳細
|
| GDC-0326 |
GDC0326 |
1282514-88-8 |
詳細
|
| 5-((benzyloxy)methyl)-4-chloro-5H-pyrrolo3,2-dpyrimidine |
|
1396316-98-5 |
詳細
|
| 1H-Inden-1-ol, 4-amino-2,3-dihydro- |
|
913296-92-1 |
詳細
|
| Danusertib |
達魯舍替 |
827318-97-8 |
詳細
|
| Ceritinib |
色瑞替尼 |
1032900-25-6 |
詳細
|
| Defactinib |
地法替尼 |
1073154-85-4 |
詳細
|
| THZ531 |
THZ531 |
1702809-17-3 |
詳細
|
| 4-(3-chlorophenyl)butanoicacid |
4-(3-氯苯基)-丁酸 |
22991-05-5 |
詳細
|
| 4-(3-FLUORO-BENZYLOXY)-PHENYLAMINE |
拉帕替尼雜質(zhì)B |
202197-25-9 |
詳細
|
| Milciclib |
PHA-848125 |
802539-81-7 |
詳細
|
| AZD-1480 |
5-氯-N2-[(1S)-1-(5-氟-2-嘧啶基)乙基]-N4-(5-甲基-1H-吡唑-3-基)-2,4-嘧啶二胺 |
935666-88-9 |
詳細
|
| 1-(2-Methyl-1H-inden-7-yl)naphthalene |
2-甲基-7-(1-萘基)茚 |
154380-68-4 |
詳細
|
| Altiratinib |
ALTIRATINIB |
1345847-93-9 |
詳細
|
| Panulisib |
AK151761; AK 151761; AK-151761 |
1356033-60-7 |
詳細
|
| 1-(6-Bromo-pyridin-2-yl)-3-methyl-1H-pyrazole-4-carboxylic acid ethyl ester |
1-(6-溴吡啶-2-基)-5-甲基-1H-吡唑-4-羧酸乙酯 |
1536648-98-2 |
詳細
|
| TP-3654 |
TP3654 |
1361951-15-6 |
詳細
|
| Quisinostat HCl |
N-HYDROXY-2-[4-[[(1-METHYLINDOL-3-YL)METHYLAMINO]METHYL]PIPERIDIN-1-YL]PYRIMIDINE-5-CARBOXAMIDE,HYDROCHLORIDE |
1083078-98-1 |
詳細
|
| 3,4'-Bipyridin]-2'-amine, 6-chloro- |
3,4'-聯(lián)吡啶]-2'-胺,6-氯- |
1817679-24-5 |
詳細
|
| Benzamide, 4-bromo-3-ethyl- |
4-溴-3-乙基苯甲酰胺 |
1253107-48-0 |
詳細
|